Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01556893
Other study ID # CS-004f
Secondary ID
Status Completed
Phase Phase 1
First received March 15, 2012
Last updated October 23, 2014
Start date April 2012
Est. completion date March 2013

Study information

Verified date October 2014
Source Alcon LenSx, Inc.
Contact n/a
Is FDA regulated No
Health authority Hungary: Research Ethics Medical CommitteeHungary: Institutional Ethics Committee
Study type Interventional

Clinical Trial Summary

This will be a prospective, single-center clinical trial of up to 50 eyes of subjects scheduled to undergo LASIK surgery requiring an initial corneal flap. Subjects will be screened for eligibility.

Subjects will undergo LASIK surgery using the LenSx Laser to create the corneal flap prior to excimer laser treatment.

Subjects will be evaluated intraoperatively to assess the ease of lifting the flaps, the stromal bed quality, and the amount of opaque bubble layer. All patients will be followed with routine vision exams for 3 months postoperatively to evaluate changes in visual acuity, manifest refraction, slit lamp examination, and endothelial cell counts.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date March 2013
Est. primary completion date March 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Must have myopia or hyperopia eligible for femtosecond initiated LASIK surgery

2. Must be over 18 years of age

3. Must have visual acuity correctable to at least 20/25 in both eyes

4. If subject is a contact lens wearer, discontinuation of contact lens wear prior to preoperative exam (2 weeks prior for soft contact lenses, 4 weeks prior for rigid gas permeable contact lenses, and 8 weeks prior for hard contact lenses)

5. Must be willing and able to return for scheduled follow up examinations through 3 months after surgery

6. Must sign and be given a copy of the written Informed Consent form

7. Postoperative refractive target is emmetropia

Exclusion Criteria:

1. Known sensitivity to planned study concomitant medications

2. Participation in any other ophthalmic drug or device clinical trial during the time of this clinical investigation

3. Presenting any contraindications to femtosecond initiated LASIK

4. Corneal thickness values that will result in residual bed less than 280 microns when flap resection and excimer ablation are calculated

5. Irregular astigmatism, based on Investigator's judgment

6. Undergoing monovision LASIK

7. Pregnant, lactating or plan to become pregnant during the course of this study

8. For bilateral second study eyes only: The surgeon shall not proceed with the second eye until the 1 week exam of the first eye shows no vision threatening complications.

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
LenSx Laser
The LenSx laser system is a femtosecond laser that has received 510(k) clearance for anterior capsulotomy during cataract surgery (K082947), laser phacofragmentation during cataract surgery (K094052) and for use in the creation of a single and multi-plane arc cut/incisions in the cornea (K092647).

Locations

Country Name City State
Hungary Department of Ophthalmology, Semmelweis University Budapest

Sponsors (1)

Lead Sponsor Collaborator
Alcon LenSx, Inc.

Country where clinical trial is conducted

Hungary, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ease of Lifting Flaps 0 - Unable to lift flap
- Able to lift flap with aid of sharp instrument
- Able to lift flap with difficulty using blunt instrument
- Able to lift flap with moderate resistance using blunt instrument
- Able to lift flap with minimal resistance using blunt instrument
- Able to lift flap without any resistance using blunt instrument (Scale)
Operative Yes
Secondary Stromal Bed Quality 0 - very rough
1- moderately rough 2 - rough 3 - smooth 4 - moderately smooth 5 - very smooth (Scale)
Operative Yes
See also
  Status Clinical Trial Phase
Recruiting NCT04923841 - Myopia Control Using Bright Light Therapy, Myopic Defocus and Atropine N/A
Active, not recruiting NCT04080128 - Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control N/A
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Completed NCT04604405 - Effects of 650nm Low Energy Light on Human Retina and Choroid Microcirculation N/A
Recruiting NCT05594719 - The Effect of Sun-like Spectrum With Different Spectrum Composition on Retinal Blood Flow N/A
Completed NCT05594732 - The Effects of Different Outdoor Light Exposure Modes on Retinal Blood Flow N/A
Completed NCT04492397 - Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI) N/A
Completed NCT04536571 - Vision Stability and Preference for Soft Toric vs. Soft Spherical Contact Lenses N/A
Completed NCT06046209 - Comparing a Monthly Replacement Lens Versus a Daily Disposable Lens N/A
Recruiting NCT06344572 - Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia Phase 3
Recruiting NCT05611294 - Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction N/A
Completed NCT05656885 - Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact Lenses N/A
Active, not recruiting NCT05534022 - Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression. N/A
Completed NCT03934788 - the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT03701516 - Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2 N/A
Completed NCT05538754 - Post-Market Evaluation of the EVO ICL N/A
Completed NCT03139201 - Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT02555722 - Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear N/A
Not yet recruiting NCT06009458 - Acuity 200™ (Fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear N/A
Recruiting NCT05548478 - Corneal Endothelial Cell Injury Induced by Mitomycin-C N/A